GO:0033270 paranode region of axon: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033270 (paranode region of axon) is the axon part adjacent to the nodes of Ranvier, surrounded by the lateral loop portions of the myelin sheath.
• The paranode forms a septate-like junction that anchors myelin lateral loops to the axolemma and is essential for saltatory conduction and axonal integrity.
• Autoimmune nodo-paranodopathies are a distinct group of peripheral neuropathies in which autoantibodies target nodal and paranodal proteins, including neurofascin-155, contactin-1 and Caspr1.
• Paranodal disruption is not limited to peripheral nerve disease; it has been linked to schizophrenia-related molecular changes and to major depression with altered paranode length in the prefrontal cortex.
• The paranode also functions as a local degradative centre in alpha-motor axons, highlighting its role in axonal turnover and homeostasis.
• Modern research on the paranode uses CRISPR knockout, point-mutation, knock-in and overexpression cell models combined with imaging, electrophysiology and transcriptomic readouts.
Description
The paranode region of axon (GO:0033270) is a specialized axonal domain that sits immediately adjacent to the nodes of Ranvier and is enclosed by the lateral loop portions of the myelin sheath. It is a cellular component of the myelinated axon, and its precise molecular architecture is required for the rapid, saltatory conduction of action potentials along myelinated nerve fibers. The paranode is not merely a passive structural boundary; it is an active signalling and adhesion hub that helps organize the node-paranode-paranode region as a functional unit. Because the paranode is positioned at the interface between the axon and its myelinating glia, it is uniquely vulnerable to autoimmune attack, genetic disruption and degenerative changes. Over the past decade, the concept of nodo-paranodopathies has emerged from clinical and translational research, defining a group of neuropathies in which autoantibodies target proteins of the node and paranode, such as neurofascin-155, contactin-1 and Caspr1. Beyond the peripheral nervous system, paranodal abnormalities have been observed in central nervous system contexts, including schizophrenia-related dysregulation of aquaporin 3 and altered paranode length in the prefrontal cortex of subjects with major depression. These findings position GO:0033270 as a clinically and biologically important term for neuroscientists, neuropathologists and gene-editing researchers. Understanding the paranode at the level of its constituent proteins, its assembly and its regulation is therefore essential for interpreting myelin biology and for developing targeted models of demyelinating and neuropsychiatric disease.
paranode region of axon At A Glance
| GO ID | GO:0033270 |
|---|---|
| GO term | paranode region of axon |
| Ontology | cellular_component |
| Synonym | paranode |
| Definition | An axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath. |
| Major function | Anchors myelin lateral loops to the axolemma and supports saltatory conduction and axonal integrity. |
| Related disease area | Autoimmune nodo-paranodopathies, demyelinating neuropathies and neuropsychiatric conditions. |
| Key molecular components | Neurofascin-155, contactin-1, Caspr1 and related cell adhesion molecules. |
| Research methods | Immunofluorescence, electron microscopy, electrophysiology, CRISPR editing and transcriptomics. |
What Is GO:0033270?
According to the Gene Ontology, GO:0033270 (paranode region of axon) is defined as an axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath. In simpler terms, it is the short segment of the axon that lies next to a node of Ranvier and is wrapped by the innermost lateral loops of the myelin-forming cell. The synonym paranode is commonly used in the literature.
Why Is paranode region of axon Important in Cell Biology?
The paranode region of axon is important because it is the structural and functional link between the myelin sheath and the axon, and its disruption leads to conduction failure, axonal degeneration and human disease. Autoimmune nodo-paranodopathies demonstrate that targeting paranodal proteins such as neurofascin-155, contactin-1 and Caspr1 produces distinct clinical phenotypes, making the paranode a direct therapeutic and diagnostic target. In the central nervous system, paranodal changes have been associated with schizophrenia-related molecular dysregulation and with major depression, suggesting that this domain contributes to psychiatric as well as neurological disorders. The paranode also serves as a local degradative centre in alpha-motor axons, indicating roles beyond conduction. Finally, flexible ensheathment of axons in complex CNS networks depends on precise myelin-axon interactions that include paranodal organization, making GO:0033270 relevant to developmental and systems neuroscience.
• The paranode is required for saltatory conduction and normal nerve impulse propagation.
• It anchors myelin lateral loops to the axolemma through septate-like junctions.
• Autoantibodies against paranodal proteins cause autoimmune nodo-paranodopathies with distinct clinical features.
• Paranodal disruption has been linked to schizophrenia-related aquaporin 3 dysregulation and reduced neuronal viability.
• Paranode length is altered in the prefrontal cortex of subjects with major depression and in chronically stressed rats.
• The node-paranode region can act as a local degradative centre in alpha-motor axons.
• Paranodal pathology is relevant to chronic inflammatory demyelinating polyradiculoneuropathy and related disorders.
• Flexible ensheathment of axons in complex CNS networks depends on myelin-axon interactions that include paranodal organization.
• The paranode is a practical target for CRISPR-based disease modelling of demyelinating and psychiatric conditions.
• Studying GO:0033270 helps connect molecular adhesion biology to clinical neuropathology.
What Happens During paranode region of axon?
Formation of the node-paranode-paranode unit
In simple terms: The paranode is built next to the node of Ranvier as part of a three-part functional unit.
The node-paranode-paranode region is a continuous structural and functional unit in myelinated nerve fibers, in which the paranode flanks the node of Ranvier on both sides. This arrangement concentrates voltage-gated sodium channels at the node while the paranode provides the adhesion and diffusion barrier that separates the nodal domain from the juxtaparanodal region. The precise geometry of this unit is essential for rapid action potential propagation.
Myelin lateral loop anchoring
In simple terms: The paranode glues the edges of the myelin sheath to the axon surface.
The paranode is surrounded by lateral loop portions of the myelin sheath, and these loops form septate-like junctions with the axolemma. This anchoring is mediated by cell adhesion molecules including neurofascin-155, contactin-1 and Caspr1, which together create a diffusion barrier between the node and the internode. Disruption of these interactions leads to paranodal destabilization and conduction abnormalities.
Maintenance of axonal integrity and turnover
In simple terms: The paranode also helps the axon clean up and maintain itself.
Node-paranode regions can act as local degradative centres in alpha-motor axons, participating in the turnover of axonal components. This degradative activity suggests that the paranode is not only a static adhesion site but also a dynamic compartment involved in axonal homeostasis. Loss of paranodal integrity may therefore contribute to axonal degeneration in neuropathies.
Paranodal changes in disease and stress
In simple terms: The paranode can change its length and molecular state in disease and stress.
Paranode length is altered in the prefrontal cortex of subjects with major depression and in rats under chronic unpredictable stress, indicating that this domain is plastic under pathological conditions. In schizophrenia-related models, disruption of the paranode influences aquaporin 3 dysregulation and neuronal viability. These findings link paranodal biology to psychiatric and stress-related disorders.
Key Genes Involved in GO:0033270 paranode region of axon
The following genes and proteins are central to the structure, function and pathology of the paranode region of axon (GO:0033270).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NFASC | Encodes neurofascin-155, a key paranodal cell adhesion molecule | Autoantibody target in autoimmune nodo-paranodopathies |
| CNTN1 | Encodes contactin-1, a paranodal adhesion protein | Autoantibody target and candidate for demyelinating neuropathy models |
| CNTNAP1 | Encodes Caspr1, a paranodal junction component | Mutations and autoantibodies linked to paranodal dysfunction |
| NRCAM | Neuron-glia-related cell adhesion molecule involved in axonal domains | Candidate for studies of node-paranode organization |
| SCN1A | Voltage-gated sodium channel subunit enriched at nodes adjacent to paranodes | Relevant to excitability and conduction studies |
| KCNQ2 | Potassium channel subunit contributing to nodal/paranodal excitability | Model for electrophysiological analysis of paranodal function |
| AQP3 | Aquaporin 3, dysregulated upon paranode disruption | Schizophrenia-related molecular readout |
| MBP | Myelin basic protein, a major myelin sheath component | Marker of myelin lateral loops surrounding the paranode |
| PLP1 | Proteolipid protein 1, a myelin structural protein | Relevant to myelin ensheathment and paranodal organization |
| MAG | Myelin-associated glycoprotein involved in axon-glia interactions | Candidate for adhesion studies at the paranode |
| CNTN2 | Contactin-2/TAG-1, a juxtaparanodal adhesion molecule | Helps define paranodal-juxtaparanodal boundaries |
| CASPR2 | Encodes contactin-associated protein 2, a juxtaparanodal protein | Autoantibody target in related nodo-paranodopathies |
| LGI1 | Leucine-rich glioma-inactivated 1, linked to juxtaparanodal complexes | Relevant to autoimmune and excitability studies |
| ANK3 | Ankyrin-G, a cytoskeletal adaptor at the node-paranode region | Candidate for cytoskeletal organization studies |
| SPTBN1 | Beta-spectrin, part of the axonal cytoskeleton at nodes and paranodes | Model for cytoskeletal anchoring research |
| SIRT2 | Sirtuin 2, implicated in myelin and paranodal biology | Candidate for regulatory studies |
| ERBB2 | Neuregulin receptor involved in myelination and glial signaling | Relevant to ensheathment and paranodal assembly |
| ERBB3 | Neuregulin receptor partner in myelinating glia | Model for myelin-axon interaction studies |
How Is paranode region of axon Regulated?
The paranode region of axon is regulated at multiple levels, including cell adhesion molecule interactions, cytoskeletal anchoring and autoimmune targeting. Neurofascin-155, contactin-1 and Caspr1 form a core adhesion complex whose disruption destabilizes the paranodal junction and alters conduction. Autoantibodies against these proteins define autoimmune nodo-paranodopathies and provide evidence that the paranode is an antibody-accessible regulatory target. In the central nervous system, paranode length and molecular composition are modulated by stress and psychiatric disease states, as shown by altered paranode length in the prefrontal cortex of subjects with major depression and in chronically stressed rats. Paranodal disruption also influences aquaporin 3 regulation and neuronal viability in schizophrenia-related contexts. Together, these findings indicate that the paranode is dynamically regulated by immune, stress-related and glial signals.
paranode region of axon and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NFASC | Autoimmune nodo-paranodopathy | Knockout or point-mutation iPSC-derived neurons |
| CNTN1 | Autoimmune nodo-paranodopathy and demyelinating neuropathy | Knock-in of patient-derived variants in cell models |
| CNTNAP1 | Paranodal junction dysfunction | CRISPR knockout in myelinating co-cultures |
| AQP3 | Schizophrenia-related dysregulation upon paranode disruption | Overexpression and knockout in neuronal cell lines |
| MBP | Myelin sheath and paranodal organization | Tagged knock-in for imaging myelin lateral loops |
Autoimmune nodo-paranodopathies
Autoimmune nodo-paranodopathies are a group of peripheral neuropathies in which autoantibodies target nodal and paranodal proteins, including neurofascin-155, contactin-1 and Caspr1. These conditions have distinct clinical features, pathophysiology and treatment responses compared with classic demyelinating neuropathies, and they highlight the paranode as a direct autoimmune target. Recognition of nodo-paranodopathies has changed diagnostic and therapeutic approaches in peripheral nerve disease.
Demyelinating and inflammatory neuropathies
Pathology of initial axon segments and node-paranode regions is relevant to chronic inflammatory demyelinating polyradiculoneuropathy and related disorders. Nodes, paranodes and neuropathies are closely linked, and paranodal disruption contributes to conduction failure and axonal damage. These observations support the paranode as a biomarker and mechanistic focus in inflammatory neuropathies.
Psychiatric and stress-related disorders
Dysregulation of schizophrenia-related aquaporin 3 through disruption of the paranode influences neuronal viability, linking paranodal biology to schizophrenia-related molecular pathways. Paranode length is altered in the prefrontal cortex of subjects with major depression and in rats under chronic unpredictable stress, suggesting that paranodal changes accompany mood disorders. These findings expand the disease relevance of GO:0033270 beyond classical neuropathy.
Axonal degeneration and turnover
Node-paranode regions can act as local degradative centres in alpha-motor axons, implicating the paranode in axonal turnover and degeneration. When paranodal integrity is lost, the local degradative and adhesive functions may be impaired, contributing to axonal pathology. This positions the paranode as a potential target for neuroprotective strategies.
From paranode region of axon-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NFASC disrupt paranodal junctions? | NFASC knockout cell model |
| Do patient-derived CNTN1 variants alter paranodal adhesion? | CNTN1 point-mutation knock-in |
| How does Caspr1 localization change at the paranode? | CNTNAP1 tagged knock-in |
| Does paranode disruption alter aquaporin 3 levels? | AQP3 overexpression and knockout |
| How does stress affect paranode length? | Chronic unpredictable stress rat model |
| Can flexible ensheathment be modelled in vitro? | Myelinating co-culture with edited glia |
How to Study the paranode region of axon Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence | Paranodal protein localization and length | Tissue and cell culture studies |
| Electron microscopy | Ultrastructure of node-paranode region | Anatomical analysis of myelinated fibers |
| Electrophysiology | Conduction velocity and block | Functional assessment of paranodal integrity |
| Transcriptomics | Gene expression changes after paranode disruption | Schizophrenia-related molecular studies |
| Autoantibody assays | Antibodies against paranodal proteins | Diagnosis of nodo-paranodopathies |
| CRISPR knockout | Loss-of-function effects on paranode | Candidate gene validation |
| Knock-in models | Variant-specific paranodal phenotypes | Disease variant modelling |
| Co-culture myelination | Myelin ensheathment and paranodal organization | CNS network myelination studies |
Imaging the paranode
Immunofluorescence and electron microscopy are standard methods for visualizing the paranode and measuring paranode length and myelin lateral loop organization. These approaches can resolve the node-paranode-paranode unit and detect disruption of adhesion molecules. In disease models, imaging reveals paranodal changes in the prefrontal cortex and peripheral nerve.
Electrophysiology
Electrophysiological recordings assess saltatory conduction and the functional consequences of paranodal disruption. Because the paranode is essential for rapid impulse propagation, conduction velocity and block are key readouts. These methods are used in both peripheral nerve and central nervous system preparations.
Molecular and transcriptomic profiling
Transcriptomic and molecular profiling can detect dysregulation of paranode-related genes such as AQP3 following paranodal disruption. These methods help link structural changes at the paranode to downstream neuronal viability pathways. They are also useful for identifying new components of the node-paranode region.
Autoantibody and clinical assays
Detection of autoantibodies against neurofascin-155, contactin-1 and Caspr1 is central to diagnosing autoimmune nodo-paranodopathies. Clinical and serological assays connect paranodal biology to patient phenotypes and treatment decisions. These assays complement experimental models of paranodal disruption.
How CRISPR Can Be Used to Study GO:0033270 paranode region of axon
Knockout
CRISPR knockout of paranodal genes such as NFASC, CNTN1 or CNTNAP1 can be used to test whether these proteins are required for paranodal junction formation and maintenance. Knockout cell models allow researchers to measure changes in paranode length, adhesion and conduction-related phenotypes. These models are foundational for causal inference in paranode biology.
Point Mutation
Point-mutation models can introduce disease-associated variants into genes such as CNTN1 to determine whether specific residues alter paranodal adhesion or stability. Such models are valuable for dissecting autoantibody epitopes and variant-specific mechanisms. They complement knockout studies by separating loss-of-function from neomorphic effects.
Knock-in
Knock-in of tagged alleles, for example tagged CNTNAP1 or MBP, enables precise visualization of paranodal proteins and myelin lateral loops in live or fixed cells. Tagged knock-in models help track protein localization during paranode assembly and in disease states. They are also useful for validating antibody specificity in paranodal research.
Overexpression
Overexpression of genes such as AQP3 can model the molecular consequences of paranode disruption and test whether increased expression affects neuronal viability. Overexpression models are useful when a disease state is associated with upregulation rather than loss of function. They can be combined with knockout to establish bidirectional causality.
How EDITGENE Supports paranode region of axon Research
Researchers studying paranode region of axon-related genes often need to determine whether a candidate gene is causally involved in paranodal assembly, maintenance or disease. EDITGENE provides the full spectrum of CRISPR cell models and screening services required to move from correlation to mechanism in GO:0033270 research.
Contact EDITGENE today to design your custom CRISPR model for paranode region of axon research.
Frequently Asked Questions About paranode region of axon
What is the paranode region of axon (GO:0033270)?
It is an axon part located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of the myelin sheath, as defined by the Gene Ontology.
What genes are involved in the paranode region of axon?
Key genes include NFASC, CNTN1 and CNTNAP1, which encode neurofascin-155, contactin-1 and Caspr1, respectively.
Why is the paranode important for nerve conduction?
The paranode anchors myelin lateral loops to the axon and helps separate nodal and internodal domains, which is required for saltatory conduction.
What diseases are linked to paranode dysfunction?
Autoimmune nodo-paranodopathies, demyelinating neuropathies, schizophrenia-related molecular changes and major depression have been linked to paranodal dysfunction.
What are autoimmune nodo-paranodopathies?
They are peripheral neuropathies caused by autoantibodies against nodal and paranodal proteins such as neurofascin-155, contactin-1 and Caspr1.
How is the paranode studied experimentally?
Common methods include immunofluorescence, electron microscopy, electrophysiology, transcriptomics and CRISPR-based gene editing.
Can CRISPR be used to model paranode-related diseases?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models can be used to test causal roles of paranodal genes in disease.
Is the paranode only found in the peripheral nervous system?
No, paranodal organization is relevant to central nervous system myelination as well, including flexible ensheathment of axons in complex CNS networks.
What is the relationship between the paranode and the node of Ranvier?
The paranode is located immediately adjacent to the node of Ranvier and forms part of the node-paranode-paranode functional unit.
How does stress affect the paranode?
Paranode length is altered in the prefrontal cortex of subjects with major depression and in rats under chronic unpredictable stress.
Conclusion
GO:0033270 (paranode region of axon) defines a critical axonal domain that anchors myelin lateral loops, supports saltatory conduction and participates in axonal homeostasis. Its clinical relevance spans autoimmune nodo-paranodopathies, demyelinating neuropathies and psychiatric conditions such as schizophrenia and major depression. As research increasingly connects paranodal molecular architecture to disease mechanisms, CRISPR-based cell models and screening approaches will be essential for causal validation. EDITGENE provides the tools needed to study this domain from gene to function.
References
- 1. Uncini A. 2023. Autoimmune nodo-paranodopathies 10 years later: Clinical features, pathophysiology and treatment.. J Peripher Nerv Syst 28 Suppl 3:S23-S35 PMID: 37272673
- 2. Kunisawa K et al.. 2018. Dysregulation of schizophrenia-related aquaporin 3 through disruption of paranode influences neuronal viability.. J Neurochem 147(3):395-408 PMID: 30025158
- 3. Berthold CH et al.. 1983. Electrophysiology and morphology of myelinated nerve fibers. VI. Anatomy of the paranode-node-paranode region in the cat.. Experientia 39(9):964-76 PMID: 6884495
- 4. Fehmi J et al.. 2018. Nodes, paranodes and neuropathies.. J Neurol Neurosurg Psychiatry 89(1):61-71 PMID: 28819062
- 5. Dziadkowiak E et al.. 2022. Pathology of Initial Axon Segments in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders.. Int J Mol Sci 23(21) PMID: 36362407
- 6. Gatzinsky KP. 1996. Node-paranode regions as local degradative centres in alpha-motor axons.. Microsc Res Tech 34(6):492-506 PMID: 8842019
- 7. Miguel-Hidalgo JJ et al.. 2025. Paranode length in the prefrontal cortex of subjects with major depression and rats under chronic unpredictable stress.. J Affect Disord 373:158-165 PMID: 39743147
- 8. Call CL et al.. 2026. Flexible ensheathment of axons enables myelination of complex CNS networks.. Nature 654(8119):724-733 PMID: 41922759
